Global Hospital Information System (HIS) Market Analysis: Strategic Insights into Digital Transformation, Interoperability, and AI-Driven Patient Care (2026-2031)

By: HDIN Research Published: 2026-03-07 Pages: 131
Market Research Report Price
  • Single User License (1 Users) $ 3,500
  • Team License (2~5 Users) $ 4,500
  • Corporate License (>5 Users) $ 5,500
Hospital Information System (HIS) Market Summary
Industry Overview and Market Dynamics
The Hospital Information System (HIS) is the digital infrastructure that serves as the central nervous system for modern healthcare facilities. These systems integrate various aspects of hospital operations, including clinical, administrative, financial, and legal workflows, into a unified platform. The primary goal of an HIS is to improve the quality of patient care while optimizing operational efficiency and reducing costs through the elimination of paperwork and the automation of data management.
The industry is currently undergoing a transformative shift from legacy on-premise solutions to cloud-based, AI-integrated platforms. This evolution is driven by the global mandate for "Universal Health Coverage" and the increasing complexity of patient data. Modern HIS solutions are no longer just storage repositories; they are active tools that facilitate real-time clinical decision-making and seamless data exchange between disparate healthcare entities.
As of 2026, the global market size for Hospital Information Systems is estimated to range between 36.5 billion USD and 65.6 billion USD. The sector is poised for steady expansion, with a projected Compound Annual Growth Rate (CAGR) of 7.0% to 9.0% through 2031. This growth is underpinned by two primary drivers: the aging global population requiring more intensive hospital resources and the rapid adoption of digital health policies in emerging economies. Furthermore, the convergence of consumer electronics and clinical data—evidenced by major technology firms entering the healthcare integration space—is creating a new paradigm for how patient health is monitored outside hospital walls.
Regional Market Analysis
The geographical distribution of the HIS market reflects the varying levels of digital maturity, government funding models, and regulatory environments across the globe.
• North America
North America remains the largest regional market for HIS, holding an estimated share of 35% to 42%. The region's dominance is sustained by the widespread implementation of the HITECH Act and subsequent interoperability mandates in the United States. The market here is characterized by a high degree of consolidation among major vendors and a pivot toward "Value-Based Care" platforms. Recent strategic activities, such as the acquisition of MedAllies by Centauri Health Solutions in 2025, highlight the North American focus on Qualified Health Information Networks (QHIN) and the exchange of clinical data at scale. The demand for advanced cybersecurity modules within HIS is also highest in this region due to the prevalence of high-profile data breaches.
• Europe
Europe represents a significant market share, estimated between 22% and 28%. The European market is highly fragmented due to differing national healthcare systems, yet it is currently seeing a wave of cross-border digitization initiatives under the "European Health Data Space" (EHDS). Germany, France, and the UK are the primary engines of growth. The market in Europe is driven by high-purity clinical workflows and specialized modules. For instance, the German-based NEXUS AG has been aggressively expanding its footprint, recently acquiring specialized business lines like OPENLIS in late 2024 to enhance laboratory management within the hospital setting. The focus in Europe is heavily weighted toward data privacy and the integration of specialized diagnostic software into the core HIS.
• Asia-Pacific (APAC)
Asia-Pacific is the fastest-growing regional market, with an estimated share ranging from 20% to 27%. Growth is fueled by massive government-led digital health transformations in China, India, and Southeast Asia. In China, the "Healthy China 2030" initiative is driving hospitals to upgrade to Tier 3 digital standards. In Taiwan, China, the market is highly sophisticated, with hospitals often acting as global testbeds for AI-integrated HIS modules and smart-ward technologies. The region's growth rate is expected to be at the upper end of the 7.0%-9.0% range, supported by the rapid construction of new hospital facilities and a burgeoning middle class seeking premium healthcare services.
• Middle East and Africa (MEA)
The MEA region is an emerging powerhouse in the HIS market, estimated to hold a share of 5% to 9%. The Gulf Cooperation Council (GCC) countries, particularly the UAE and Saudi Arabia, are investing billions in "Smart Hospital" infrastructure. High-profile transactions, such as PureHealth’s multi-billion dollar acquisition of a majority stake in Hellenic Healthcare Group in early 2025, signal the region's intent to build globalized, digitally-integrated provider networks. The demand in MEA is focused on "greenfield" projects where HIS can be built into the facility design from day one.
• South America
South America accounts for an estimated 4% to 7% of the global market. While currently smaller in scale, countries like Brazil and Chile are seeing a steady transition from paper-based records to Electronic Health Records (EHR) as part of national public health reforms. The market is largely driven by private hospital groups that utilize HIS to differentiate their services and improve patient retention.
Application and Type Analysis
The HIS market is segmented by functional modules, each reflecting a specific aspect of the patient journey and hospital administration.
• Electronic Health Record (EHR)
The EHR remains the core application of the HIS market. It serves as the digital version of a patient’s paper chart, containing medical history, diagnoses, medications, and treatment plans. The trend in EHR is toward "mobile-first" access and patient-facing portals. EHRs are increasingly incorporating social determinants of health (SDoH) data to provide a more holistic view of patient outcomes.
• Clinical Information System (CIS)
CIS modules are specialized tools for clinical departments such as the laboratory (LIS), pharmacy, and radiology (RIS). The market is seeing a trend toward deep vertical integration; as noted by NEXUS AG’s acquisition of OPENLIS, hospitals are moving away from siloed departmental software toward CIS modules that are natively integrated into the central HIS to ensure data consistency across the care continuum.
• Practice Management Software (PMS)
PMS focuses on the administrative side, including patient scheduling, billing, and insurance claims processing. With the rising complexity of global healthcare reimbursement models, there is a significant demand for PMS that can handle multiple insurance schemes and provide automated revenue cycle management (RCM).
• Clinical Decision Support System (CDSS)
CDSS is the most technologically advanced segment, utilizing AI and machine learning to provide clinicians with evidence-based diagnostic suggestions and alerts for potential drug interactions. The integration of CDSS is moving from simple alerts to proactive population health management tools that identify at-risk patients before they require acute intervention.
Value Chain and Industry Structure
The HIS value chain is shifting from a linear software-sales model to a circular, data-driven ecosystem.
1. Upstream: Infrastructure and Enabling Technologies
This includes cloud service providers (AWS, Azure, Oracle Cloud), database management systems, and cybersecurity firms. A significant new addition to the upstream segment is the "integration platform" layer. Samsung Electronics’ 2025 acquisition of Xealth highlights the growing importance of platforms that can bridge consumer-facing digital health tools (like wearables) with clinical HIS workflows.
2. Midstream: HIS Software Development and Integration
This is the heart of the market, where companies like Oracle (Cerner), NEXUS, and CompuGroup Medical design and build the HIS architecture. This stage involves massive R&D in UI/UX design, interoperability standards (HL7, FHIR), and AI modeling. The midstream also includes third-party integrators who help hospitals migrate their legacy data to new systems.
3. Downstream: Deployment and End-Use
The end-users are primarily multi-specialty hospitals, outpatient clinics, and government health departments. A key trend at this stage is "Healthcare Outsourcing Solutions." The acquisition of GeBBS by EQT Private Capital Asia in late 2024 demonstrates that many hospitals are now outsourcing the management of their HIS-related financial and administrative data to specialized providers to focus on clinical care.
4. Post-Deployment: Support and Continuous Optimization
This involves continuous software updates, training for medical staff, and the use of data analytics to refine hospital operations. As HIS becomes more complex, the role of 24/7 technical support and cybersecurity monitoring has become a non-discretionary part of the value chain.
Key Market Players and Strategic Evolution
The competitive landscape is defined by traditional IT giants, specialized healthcare software firms, and aggressive new entrants from the private equity and consumer tech sectors.
• NEXUS AG
NEXUS AG is a European leader in healthcare software, known for its modular and highly adaptable HIS solutions. The company’s strategy focuses on "Total Hospital Solutions," ensuring that every department—from the ICU to the laboratory—is digitally connected. Their 2024 acquisition of OPENLIS demonstrates a strategic commitment to vertical integration, bringing laboratory diagnostics into the core of their software ecosystem. This move positions NEXUS as a primary choice for European hospitals seeking to consolidate their software vendors.
• Oracle (Oracle Health/Cerner)
Following its acquisition of Cerner, Oracle has become one of the most powerful forces in the HIS market. Oracle’s strategy is built on the integration of clinical data with its massive cloud and database infrastructure. They are currently focusing on the application of "Autonomous Database" technology to healthcare, aiming to reduce the administrative burden on clinicians through AI-powered voice recognition and automated clinical charting.
• IQVIA
IQVIA sits at the intersection of data science, technology, and clinical research. While traditionally focused on the pharmaceutical industry, IQVIA’s HIS offerings leverage their massive global data sets to provide superior clinical decision support and population health analytics. Their presence in the market is vital for hospitals that are heavily involved in clinical trials and academic research.
• Infosys
Infosys provides large-scale digital transformation services for healthcare providers. Their role in the HIS market is often as a strategic integrator and cloud migration partner. They excel in modernizing legacy systems for large hospital chains, using AI and automation to streamline the "Patient 360" view.
• CompuGroup Medical (CGM)
CGM is a leading global e-health company with a strong presence in the ambulatory and hospital sectors. Their HIS solutions are known for high levels of security and a focus on the patient-physician relationship. CGM is a key player in the European market, particularly in Germany, where they are central to the national telematics infrastructure.
• ICON plc and Definitive Healthcare
ICON plc focuses heavily on the integration of HIS with clinical trial data, facilitating the use of "real-world evidence" (RWE) in drug development. Definitive Healthcare provides the intelligence and data analytics that hospitals use to optimize their market positioning and patient acquisition strategies.
Strategic Market Activity (2024-2025)
The HIS market has seen an unprecedented wave of M&A activity that signals the convergence of healthcare, high finance, and consumer technology.
• Private Equity Consolidation: EQT’s acquisition of GeBBS (Sept 2024) reflects a trend where private equity firms are looking to capitalize on the "back-office" digitization of healthcare. Outsourcing solutions are becoming a critical efficiency lever for hospitals.
• Cross-Border Infrastructure Growth: PureHealth’s multi-billion dollar investment in Hellenic Healthcare Group (Jan 2025) showcases the rise of international healthcare conglomerates that require unified, cross-border HIS platforms to manage global patient flows.
• The Connectivity Shift: Centauri Health Solutions’ acquisition of MedAllies (April 2025) highlights the move toward Qualified Health Information Networks (QHIN). The market is shifting from "owning the data" to "connecting the data," as clinical exchange becomes a regulatory and operational necessity.
• The Consumer-Clinical Bridge: Samsung’s 2025 acquisition of Xealth is perhaps the most forward-looking deal. By integrating a platform like Xealth, Samsung aims to place wearable data and digital health programs directly into the physician’s HIS workflow, effectively turning the HIS into a preventative care tool.
Market Opportunities and Challenges
Opportunities
• AI-Driven Operational Efficiency: The application of Generative AI to automate medical coding, summarizing patient histories, and predictive staffing represents a massive cost-saving opportunity for hospitals.
• The Interoperability Mandate: As governments mandate the use of FHIR (Fast Healthcare Interoperability Resources) standards, there is a surge in demand for HIS systems that can "talk" to other systems. Companies providing the "glue" for this data exchange are seeing rapid growth.
• Telehealth and Remote Monitoring: Post-pandemic healthcare is hybrid. HIS systems that natively support telehealth visits and the integration of remote patient monitoring (RPM) data are becoming the market standard.
• Precision Medicine: The integration of genomic data into the EHR provides a major opportunity for hospitals to offer personalized treatment plans, particularly in oncology and rare diseases.
Challenges
• Cybersecurity and Ransomware: Hospitals are prime targets for cyberattacks. The high sensitivity of health data makes the "cost of failure" for an HIS provider immense. Maintaining the security of an increasingly interconnected system is the industry's top challenge.
• Legacy System Fatigue: Many hospitals are still using systems built decades ago. The cost and technical risk of migrating "mission-critical" data to a new HIS often prevent organizations from adopting modern technologies.
• Clinician Burnout: Poorly designed HIS interfaces are a leading cause of physician burnout. The industry faces the challenge of making software that is "clinician-centric" rather than just "billing-centric."
• Data Privacy and Ethics: As AI becomes more prevalent in clinical decision support, the industry must navigate the ethical challenges of algorithmic bias and the legalities of using patient data for machine learning training.
Chapter 1 Report Overview 1
1.1 Study Scope 1
1.2 Research Methodology 2
1.2.1 Data Sources 2
1.2.2 Assumptions 4
1.3 Abbreviations and Acronyms 5
Chapter 2 Global HIS Market Executive Summary 7
2.1 Market Overview and Definition 7
2.2 Global Market Size and Growth Rate (2021-2031) 9
2.3 Market Segmentation by Type 11
2.4 Market Segmentation by Application 13
2.5 Key Regional Highlights 15
Chapter 3 Market Dynamics and Industry Trends 17
3.1 Growth Drivers: Digital Transformation in Healthcare 17
3.2 Market Restraints: Data Privacy and Interoperability Challenges 19
3.3 Market Opportunities: AI Integration and Telehealth Expansion 21
3.4 Porter's Five Forces Analysis 24
3.5 PESTEL Analysis 27
Chapter 4 Global HIS Market by Type 30
4.1 Electronic Health Record (EHR) 30
4.2 Clinical Information System (CIS) 33
4.3 Practice Management Software (PMS) 36
4.4 Clinical Decision Support System (CDSS) 39
Chapter 5 Global HIS Market by Application 42
5.1 General Hospitals 42
5.2 Specialty Clinics 45
5.3 Ambulatory Surgical Centers (ASCs) 48
5.4 Managed Care Organizations 51
Chapter 6 Global HIS Market by Deployment Mode 54
6.1 Cloud-based HIS 54
6.2 On-premise HIS 57
Chapter 7 Global HIS Market by Region 60
7.1 North America (United States, Canada) 60
7.2 Europe (Germany, UK, France, Italy) 63
7.3 Asia-Pacific 66
7.3.1 Mainland China 67
7.3.2 Taiwan (China) 69
7.3.3 Japan and South Korea 71
7.3.4 Southeast Asia and India 73
7.4 Rest of the World (excluding Russia and Iran) 75
Chapter 8 Industry Value Chain and Regulatory Analysis 77
8.1 HIS Value Chain Overview 77
8.2 Software Development and Interoperability Standards (HL7/FHIR) 79
8.3 Regulatory Framework and Healthcare Compliance 81
Chapter 9 Competitive Landscape 83
9.1 Global Top Players Revenue Ranking 2026 83
9.2 Market Concentration Ratio (CR3, CR5, CR10) 85
9.3 Strategic Alliances, Mergers, and Acquisitions 87
Chapter 10 Key Company Profiles 89
10.1 NEXUS AG 89
10.1.1 Company Profile and Core Business 89
10.1.2 SWOT Analysis 90
10.1.3 NEXUS HIS Revenue, Cost and Gross Profit Margin (2021-2026) 91
10.1.4 Product Innovation and European Market Strategy 92
10.2 IQVIA 93
10.2.1 Company Profile and Core Business 93
10.2.2 SWOT Analysis 94
10.2.3 IQVIA HIS Revenue, Cost and Gross Profit Margin (2021-2026) 95
10.2.4 Data Analytics and Clinical Research Integration 96
10.3 Infosys 98
10.3.1 Company Profile and Core Business 98
10.3.2 SWOT Analysis 99
10.3.3 Infosys HIS Revenue, Cost and Gross Profit Margin (2021-2026) 100
10.3.4 Digital Healthcare Consulting and Outsourcing Services 101
10.4 Oracle 103
10.4.1 Company Profile and Core Business 103
10.4.2 SWOT Analysis 104
10.4.3 Oracle HIS Revenue, Cost and Gross Profit Margin (2021-2026) 105
10.4.4 Cloud Infrastructure and Cerner Integration Analysis 107
10.5 ICON plc 108
10.5.1 Company Profile and Core Business 108
10.5.2 SWOT Analysis 109
10.5.3 ICON HIS Revenue, Cost and Gross Profit Margin (2021-2026) 110
10.5.4 Strategic Focus on Clinical Trial Management Systems 111
10.6 Definitive Healthcare 113
10.6.1 Company Profile and Core Business 113
10.6.2 SWOT Analysis 114
10.6.3 Definitive Healthcare HIS Revenue, Cost and Gross Profit Margin (2021-2026) 115
10.6.4 Market Intelligence and Commercial Strategy 116
10.7 CompuGroup Medical 118
10.7.1 Company Profile and Core Business 118
10.7.2 SWOT Analysis 119
10.7.3 CompuGroup HIS Revenue, Cost and Gross Profit Margin (2021-2026) 120
10.7.4 Practice Management and Connectivity Solutions 121
Chapter 11 Global HIS Market Forecast (2027-2031) 123
11.1 Global Market Revenue Forecast 123
11.2 Forecast by Type (2027-2031) 125
11.3 Forecast by Application (2027-2031) 127
11.4 Forecast by Region (2027-2031) 129
Chapter 12 Conclusion and Strategic Recommendations 131
Table 1. Global HIS Market Size by Type (USD Million) 2021-2026 11
Table 2. Global HIS Market Size by Application (USD Million) 2021-2026 13
Table 3. North America HIS Market by Country (USD Million) 2021-2026 62
Table 4. Europe HIS Market by Country (USD Million) 2021-2026 65
Table 5. Asia-Pacific HIS Market by Country (USD Million) 2021-2026 68
Table 6. Global Top HIS Players Ranking by Revenue 2026 86
Table 7. NEXUS HIS Revenue, Cost and Gross Profit Margin (2021-2026) 91
Table 8. IQVIA HIS Revenue, Cost and Gross Profit Margin (2021-2026) 95
Table 9. Infosys HIS Revenue, Cost and Gross Profit Margin (2021-2026) 100
Table 10. Oracle HIS Revenue, Cost and Gross Profit Margin (2021-2026) 105
Table 11. ICON HIS Revenue, Cost and Gross Profit Margin (2021-2026) 110
Table 12. Definitive Healthcare HIS Revenue, Cost and Gross Profit Margin (2021-2026) 115
Table 13. CompuGroup HIS Revenue, Cost and Gross Profit Margin (2021-2026) 120
Table 14. Forecast Global HIS Market Size by Type (USD Million) 2027-2031 126
Table 15. Forecast Global HIS Market Size by Application (USD Million) 2027-2031 128
Table 16. Forecast Global HIS Market Size by Region (USD Million) 2027-2031 130
Figure 1. Global HIS Market Size (USD Million) 2021-2031 9
Figure 2. Global HIS Market Share by Type in 2026 12
Figure 3. Global HIS Market Share by Application in 2026 14
Figure 4. North America HIS Market Growth (2021-2031) 61
Figure 5. Europe HIS Market Growth (2021-2031) 64
Figure 6. Asia-Pacific HIS Market Growth (2021-2031) 66
Figure 7. Taiwan (China) HIS Market Size 2021-2031 70
Figure 8. Global Top 5 HIS Players Market Share (%) in 2026 84
Figure 9. NEXUS HIS Market Share (2021-2026) 91
Figure 10. IQVIA HIS Market Share (2021-2026) 95
Figure 11. Infosys HIS Market Share (2021-2026) 100
Figure 12. Oracle HIS Market Share (2021-2026) 105
Figure 13. ICON HIS Market Share (2021-2026) 110
Figure 14. Definitive Healthcare HIS Market Share (2021-2026) 115
Figure 15. CompuGroup HIS Market Share (2021-2026) 120
Figure 16. Global HIS Market Revenue Forecast (USD Million) 2027-2031 124

Research Methodology

  • Market Estimated Methodology:

    Bottom-up & top-down approach, supply & demand approach are the most important method which is used by HDIN Research to estimate the market size.

1)Top-down & Bottom-up Approach

Top-down approach uses a general market size figure and determines the percentage that the objective market represents.

Bottom-up approach size the objective market by collecting the sub-segment information.

2)Supply & Demand Approach

Supply approach is based on assessments of the size of each competitor supplying the objective market.

Demand approach combine end-user data within a market to estimate the objective market size. It is sometimes referred to as bottom-up approach.

  • Forecasting Methodology
  • Numerous factors impacting the market trend are considered for forecast model:
  • New technology and application in the future;
  • New project planned/under contraction;
  • Global and regional underlying economic growth;
  • Threatens of substitute products;
  • Industry expert opinion;
  • Policy and Society implication.
  • Analysis Tools

1)PEST Analysis

PEST Analysis is a simple and widely used tool that helps our client analyze the Political, Economic, Socio-Cultural, and Technological changes in their business environment.

  • Benefits of a PEST analysis:
  • It helps you to spot business opportunities, and it gives you advanced warning of significant threats.
  • It reveals the direction of change within your business environment. This helps you shape what you’re doing, so that you work with change, rather than against it.
  • It helps you avoid starting projects that are likely to fail, for reasons beyond your control.
  • It can help you break free of unconscious assumptions when you enter a new country, region, or market; because it helps you develop an objective view of this new environment.

2)Porter’s Five Force Model Analysis

The Porter’s Five Force Model is a tool that can be used to analyze the opportunities and overall competitive advantage. The five forces that can assist in determining the competitive intensity and potential attractiveness within a specific area.

  • Threat of New Entrants: Profitable industries that yield high returns will attract new firms.
  • Threat of Substitutes: A substitute product uses a different technology to try to solve the same economic need.
  • Bargaining Power of Customers: the ability of customers to put the firm under pressure, which also affects the customer's sensitivity to price changes.
  • Bargaining Power of Suppliers: Suppliers of raw materials, components, labor, and services (such as expertise) to the firm can be a source of power over the firm when there are few substitutes.
  • Competitive Rivalry: For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry.

3)Value Chain Analysis

Value chain analysis is a tool to identify activities, within and around the firm and relating these activities to an assessment of competitive strength. Value chain can be analyzed by primary activities and supportive activities. Primary activities include: inbound logistics, operations, outbound logistics, marketing & sales, service. Support activities include: technology development, human resource management, management, finance, legal, planning.

4)SWOT Analysis

SWOT analysis is a tool used to evaluate a company's competitive position by identifying its strengths, weaknesses, opportunities and threats. The strengths and weakness is the inner factor; the opportunities and threats are the external factor. By analyzing the inner and external factors, the analysis can provide the detail information of the position of a player and the characteristics of the industry.

  • Strengths describe what the player excels at and separates it from the competition
  • Weaknesses stop the player from performing at its optimum level.
  • Opportunities refer to favorable external factors that the player can use to give it a competitive advantage.
  • Threats refer to factors that have the potential to harm the player.
  • Data Sources
Primary Sources Secondary Sources
Face to face/Phone Interviews with market participants, such as:
Manufactures;
Distributors;
End-users;
Experts.
Online Survey
Government/International Organization Data:
Annual Report/Presentation/Fact Book
Internet Source Information
Industry Association Data
Free/Purchased Database
Market Research Report
Book/Journal/News

Why HDIN Research.com?

More options to meet your budget: you can choose Multi-user report, customized report even only specific data you need

 

Plenty of third-party databases and owned databases support

 

Accurate market information supported by Top Fortune 500 Organizations

 

24/7 purchase support and after-service support

 

Protect customer privacy

ABOUT HDIN RESEARCH

HDIN Research focuses on providing market consulting services. As an independent third-party consulting firm, it is committed to providing in-depth market research and analysis reports.

OUR LOCATION

Room 208-069, Floor 2, Building 6, No. 1, Shangdi 10th Street, Haidian District, Beijing, PR China
+86-010-82142830
sales@hdinresearch.com

QUICK LINKS